Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development.

The dynamic process of mammary ductal morphogenesis depends on regulated epithelial proliferation and extracellular matrix (ECM) turnover. Epithelial cell-matrix contact closely dictates epithelial proliferation, differentiation, and survival. Despite the fact that tissue inhibitors of metalloproteinases (Timps) regulate ECM turnover, their function in mammary morphogenesis is unknown. We have delineated the spatiotemporal expression of all Timps (Timp-1 to Timp-4) during discrete phases of murine mammary development. Timp mRNAs were abundant in mammary tissue, each displaying differential expression patterns with predominant localization in luminal epithelial cells. Timp-1 mRNA was unique in that its expression was limited to the stage at which epithelial proliferation was high. To assess whether Timp-1 promotes or inhibits epithelial cell proliferation we manipulated mammary Timp-1 levels, genetically and biochemically. Down-regulation of epithelial-derived Timp-1 in transgenic mice, by mouse mammary tumor virus promoter-directed Timp-1 antisense RNA expression, led to augmented ductal expansion and increased number of ducts (P < 0.004). In these transgenics the integrity of basement membrane surrounding epithelial ducts, as visualized by laminin-specific immunostaining, was breached. In contrast to these mice, ductal expansion was markedly attenuated in the proximity of implanted recombinant Timp-1-releasing pellets (rTIMP-1), without an increase in basement membrane deposition around migrating terminal end buds. Epithelial proliferation and apoptosis were measured to determine the basis of altered ductal expansion. Luminal epithelial proliferation was increased by 55% (P < 0.02) in Timp-1-reduced transgenic mammary tissue and, conversely, decreased by 38% (P < 0.02) in terminal end buds by implanted rTIMP-1. Epithelial apoptosis was minimal and remained unaffected by Timp-1 manipulations. We conclude that Timps have an integral function in mammary morphogenesis and that Timp-1 regulates mammary epithelial proliferation in vivo, at least in part by maintaining basement membrane integrity.

[1]  L. Matrisian,et al.  Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. , 1996, The international journal of biochemistry & cell biology.

[2]  Z. Werb,et al.  Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene , 1996, The Journal of cell biology.

[3]  P. Waterhouse,et al.  A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. , 1986, Nucleic acids research.

[4]  G. Church,et al.  Genomic sequencing. , 1993, Methods in molecular biology.

[5]  P. Rudland,et al.  Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. , 1996, Seminars in cancer biology.

[7]  R. Heller,et al.  Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. , 1997, Critical reviews in eukaryotic gene expression.

[8]  C. Daniel,et al.  Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. , 1982, Developmental biology.

[9]  R. Timpl,et al.  Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. , 1997, European journal of biochemistry.

[10]  A. Eisen,et al.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Khokha Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. , 1994, Journal of the National Cancer Institute.

[12]  E. Hay Extracellular matrix alters epithelial differentiation. , 1993, Current opinion in cell biology.

[13]  Z. Werb,et al.  Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution , 1992, The Journal of cell biology.

[14]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Taylor,et al.  The Mechanism of Inhibition of Collagenase by TIMP-1* , 1996, The Journal of Biological Chemistry.

[16]  D. Miles,et al.  Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.

[17]  E. Boylan,et al.  Mammary gland morphology and responsiveness to regulatory molecules following prenatal exposure to diethylstilbestrol. , 1993, Teratogenesis, carcinogenesis, and mutagenesis.

[18]  D. Stern,et al.  Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  C. Q. Lin,et al.  Extracellular matrix regulates whey acidic protein gene expression by suppression of TGF-alpha in mouse mammary epithelial cells: studies in culture and in transgenic mice , 1995, The Journal of cell biology.

[20]  K. Iwata,et al.  Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.

[21]  K. Suzuki,et al.  Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. , 1994, Endocrinology.

[22]  J. Kere,et al.  Human TIMP-3 Is Expressed During Fetal Development, Hair Growth Cycle, and Cancer Progression , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  D. Gomez,et al.  Enhanced RNA expression of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) in human breast cancer , 1996, International journal of cancer.

[24]  B. Vandenbunder,et al.  Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. , 1996, The International journal of developmental biology.

[25]  S. Chandler,et al.  Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. , 1996, Biochemical and biophysical research communications.

[26]  Y. Okada,et al.  Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis , 1995, Molecular and cellular biology.

[27]  M. Bissell,et al.  Multi‐faceted regulation of cell differentiation by extracellular matrix , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Y. DeClerck,et al.  Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. , 1994, Cancer research.

[29]  A. Sonnenberg,et al.  Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  R. Khokha,et al.  Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. , 1994, The Journal of biological chemistry.

[31]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[32]  A. Riggs,et al.  Genomic sequencing. , 1993, Methods in molecular biology.

[33]  P. Leder,et al.  Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. , 1989, The American journal of pathology.

[34]  W. Stetler-Stevenson,et al.  Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activity , 1992, FEBS letters.

[35]  M. Bäckdahl,et al.  Correlation between stromelysin‐3 mRNA level and outcome of human breast cancer , 1994, International journal of cancer.

[36]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.

[37]  L. Liotta,et al.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. , 1989, The Journal of biological chemistry.

[38]  B. Vandenbunder,et al.  The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. , 1998, Journal of cell science.

[39]  S. Haslam Role of Sex Steroid Hormones in Normal Mammary Gland Function , 1987 .

[40]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  W. Fauquette,et al.  Characterization of morphogenetic and invasive abilities of human mammary epithelial cells: Correlation with variations of urokinase‐type plasminogen activator activity and type‐1 plasminogen activator inhibitor level , 1997, Biology of the cell.

[42]  M. F. Smith,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. , 1998, Reviews of reproduction.

[43]  M. Flannery,et al.  Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. , 1996, Development.

[44]  J. Fata,et al.  Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice. , 1997, Blood.

[45]  R. Dulbecco,et al.  Marker evolution during the development of the rat mammary gland: stem cells identified by markers and the role of myoepithelial cells. , 1986, Cancer research.

[46]  J. Williams,et al.  Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. , 1983, Developmental biology.

[47]  R. Langer,et al.  Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. , 1980, Journal of pharmaceutical sciences.

[48]  A. Eisen,et al.  Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.

[49]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[50]  M. Day,et al.  Cell Anchorage Regulates Apoptosis through the Retinoblastoma Tumor Suppressor/E2F Pathway* , 1997, The Journal of Biological Chemistry.

[51]  Z. Werb,et al.  Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. , 1991, Development.

[52]  S. Nandi,et al.  Regulation of mammary epithelial cell growth in mice and rats. , 1990, Endocrine reviews.

[53]  D. Gomez,et al.  Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.

[54]  M. Neville,et al.  The Mammary gland : development, regulation, and function , 1987 .

[55]  R. Wieczorek,et al.  Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. , 1995, Endocrinology.

[56]  Jack P. Witty,et al.  Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. , 1995, Molecular biology of the cell.

[57]  Z. Werb,et al.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.

[58]  Y. Konttinen,et al.  Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[59]  C H Streuli,et al.  Laminin mediates tissue-specific gene expression in mammary epithelia , 1995, The Journal of cell biology.

[60]  J. H. Dierendonck,et al.  A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[61]  Q. Sang,et al.  Complex role of matrix metalloproteinases in angiogenesis , 1998, Cell Research.

[62]  K. Suzuki,et al.  Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. , 1995, Endocrinology.

[63]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[64]  Z. Werb,et al.  Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Khokha,et al.  Murine tissue inhibitor of metalloproteinases—4 (Timp—4): cDNA isolation and expression in adult mouse tissues 1 , 1997, FEBS letters.

[66]  C. López-Otín,et al.  The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction* , 1997, The Journal of Biological Chemistry.

[67]  Y. Okada,et al.  Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. , 1987, The Journal of rheumatology.

[68]  L. Fink,et al.  Removal of basement membrane in the involuting breast. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[69]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.

[70]  R. Khokha,et al.  Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse. , 1996, Biology of reproduction.

[71]  P. Leder,et al.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.

[72]  L. Matrisian,et al.  Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. , 1996, The American journal of pathology.

[73]  T. Cawston Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. , 1998, Molecular medicine today.

[74]  L. Liotta,et al.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. , 1990, The American journal of pathology.

[75]  C. Daniel,et al.  Postnatal Development of the Rodent Mammary Gland , 1987 .

[76]  R. Khokha,et al.  Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[77]  K. Brocklehurst,et al.  Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate. , 1998, Biochemistry.

[78]  K. Suzuki,et al.  Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. , 1994, The Journal of biological chemistry.

[79]  John M. Whitelock,et al.  The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases (*) , 1996, The Journal of Biological Chemistry.

[80]  Y. Sasaguri,et al.  Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. , 1992, The Biochemical journal.

[81]  A. Shinagawa,et al.  Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.

[82]  A Yasui,et al.  Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. , 1990, European journal of biochemistry.

[83]  G. Schultz,et al.  Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. , 1995, Development.

[84]  M. Bissell,et al.  Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.